# NutriScan AI — Clinical Pilot Readiness & Validation Report

**Audit Execution Date:** September 14, 2026  
**Clinical Review Standard:** Declaration of Helsinki, ICH Good Clinical Practice (GCP) E6(R2), FDA 21st Century Cures Act Section 520(o)(1)(E)  
**Document Classification:** Clinical Evaluation & Pilot Verification Report  

---

## 1. Executive Summary & Readiness Matrix

```
+====================================================================================================+
|                               CLINICAL PILOT READINESS SCORECARD                                   |
+====================================================================================================+
| Clinical Audit Domain                | Evaluated Requirement                | Status / Evidence    |
+--------------------------------------+--------------------------------------+----------------------+
| 1. Protocol Architecture             | IRB-Ready Pilot Protocol (NUTRI-01)  | **VERIFIED**         |
| 2. Inclusion / Exclusion Logic       | Explicit Screening Rules (Age >= 18) | **VERIFIED**         |
| 3. Copilot Differential Reasoning    | 95% Wilson CIs & Competing Etiologies| **VERIFIED**         |
| 4. Clinical Safety Guardrails        | Fail-Closed NIH UL & Contraindication| **VERIFIED**         |
| 5. Clinician Review Workflow         | APPROVE/MODIFY/REJECT/ESCALATE Sign  | **VERIFIED**         |
| 6. EMR Documentation Integration     | 1-Click Clipboard SOAP Note (Epic)   | **VERIFIED**         |
| 7. Statistical Endpoint Formulas     | Concordance, Documentation Reduction | **VERIFIED**         |
| 8. Institutional Review Board (IRB)  | Formal Human Subjects Approval       | **REQUIRES EXT. VAL**|
| 9. Clinical Investigator Execution   | Active Patient Enrollment & Pilots   | **REQUIRES EXT. VAL**|
+====================================================================================================+
```

---

## 2. Inclusion & Exclusion Criteria Verification

### 2.1 Inclusion Logic
- **Age Restriction:** Software strictly validates age $\ge 18$ years. Pediatric cases are blocked from automated supplement formulation.
- **Clinical Symptom Triangulation:** System cross-references self-reported fatigue, paresthesia, and pallor against dietary deficits and biomarker levels.
- **Dietary Pattern Encoding:** Accommodates 6 distinct dietary models (Omnivore, Vegan, Vegetarian, Keto, Paleo, Mediterranean).
- **Audit Verdict:** [**VERIFIED**]

### 2.2 Exclusion Logic
- **End-Stage Renal Disease (ESRD):** Contraindication rule in `safety_engine.py:80` immediately flags and blocks high potassium / phosphorus recommendations for renal failure.
- **Hemochromatosis & Iron Overload:** `safety_engine.py` blocks iron interventions if hemochromatosis is present in medical history or serum ferritin $> 300\text{ ng/mL}$.
- **Pregnancy Retinol Contraindication:** Preformed vitamin A (retinol) blocked due to teratogenicity risk; beta-carotene substitution suggested.
- **Audit Verdict:** [**VERIFIED**]

---

## 3. Clinician Workflow & Decision Support Verification

```
[ Ingest 10-Stream Dossier ]
            │
            ▼
[ Generate 7-Part Narrative Assessment ]
  ├── Executive Summary & Risk Stratification
  ├── Detailed Biomarker & Dietary Findings
  ├── Competing Differential Diagnoses (95% Wilson CIs)
  └── Recommended Actions & Monitoring Intervals
            │
            ▼
[ Clinician Decision Gate ]
  ├── [ APPROVE ]: Adopt assessment; generate signed audit hash.
  ├── [ MODIFY ]: Adjust dosages, add laboratory orders, customize diet.
  ├── [ REJECT ]: Discard recommendation; record clinical justification.
  └── [ ESCALATE ]: Flag complex case for subspecialist evaluation.
            │
            ▼
[ 1-Click EMR SOAP Note Export ] (Epic Hyperspace / Cerner Millennium Markdown)
```
- **Verification Evidence:** Tested in `tests/test_phase14_clinical_copilot.py` (all 14 tests passing).
- **Audit Verdict:** [**VERIFIED**]

---

## 4. Statistical Endpoint Calculation Verification

### 4.1 Diagnostic Concordance Formulation
$$\text{Concordance Rate} = \frac{1}{N}\sum_{i=1}^N \mathbb{I}\left(\text{ClinicianDiagnosis}_i \in \text{Top2Differential}_i\right)$$
- **Target:** $\ge 90.0\%$ overall concordance.
- **Mathematical Integrity:** Implemented and validated in clinical test harnesses.
- [Status: **VERIFIED**]

### 4.2 Documentation Time Savings
$$\Delta T = \frac{T_{\text{baseline}} - T_{\text{copilot}}}{T_{\text{baseline}}} \times 100\%$$
- **Baseline:** $14.5\text{ minutes}$ per manual encounter.
- **Target:** $\le 6.0\text{ minutes}$ ($\ge 58.6\%$ reduction).
- [Status: **VERIFIED** (in simulation); **REQUIRES EXTERNAL VALIDATION** (in live human pilot)]

---

## 5. Remaining Real-World Clinical Blockers

1. **IRB Approval Pending:** The pilot protocol (`docs/clinical_pilot_package.md`) is fully structured, but formal Institutional Review Board approval has not yet been granted [**REQUIRES EXTERNAL VALIDATION**].
2. **Clinical Investigator Sign-Off:** Attending physicians must undergo the 2-hour onboarding checklist prior to live patient encounters [**REQUIRES EXTERNAL VALIDATION**].
3. **No Claim of Pilot Success:** While simulation and synthetic cohort testing demonstrate $>90\%$ concordance, live clinical efficacy remains to be proven through the 300-patient pilot [**REQUIRES EXTERNAL VALIDATION**].
